Arden Anglican School wins SunSafe Ambassador competition
13 December 2018
Three students from Arden Anglican School in Epping have won Melanoma Institute Australia’s (MIA) inaugural SunSafe Student Ambassador Award for their engaging and inspiring presentation to their peers about how to be sun safe and help prevent melanoma.
Year 10 students Kaela (16), Oliver (16) and Kimberley (16) were nominated by their school to join other students at MIA’s one-day SunSafe Student Ambassador Program at The Poche Centre in Wollstonecraft, where they learned about melanoma and the importance of sun safety.
The program was also designed to assist students in developing their presentation skills, so they could create a personalised sun safe presentation to deliver at their school.
The students returned to their schools to deliver their own SunSafe presentation to their peers, with nine schools submitting videos of the student presentations for judging by MIA’s expert panel, including the Chair of MIA’s Education Committee Associate Professor Robyn Saw, Director of Speak Out Schools Kat Collins, and MIA CEO Matthew Browne.
The students from Arden Anglican School were announced as the winners and were today presented with their award at the final Year 10 Meeting for the year by Melanoma Institute Australia CEO Matthew Browne.
‘I thought the three Arden ambassadors were very engaging,’ said Mr. Browne.
‘Kaela, Oliver and Kimberley’s presentation would have undoubtedly convinced many of their peers to cover up and protect themselves from the sun, a critically important message particularly for teenagers.’
UV exposure leading to sunburn is the greatest risk factor for developing melanoma. One Australian dies every five hours from melanoma, which is also the most common cancer affecting 15 to 39 year old Australians.
MIA’s SunSafe Student Ambassador Program will be rolled out in six locations across east coast of Australia in late 2019. Schools interested in participating can fill out the expression of interest form here.
Melanoma Masterclass celebrates Australian luminaries who have transformed melanoma treatment worldwide
The extraordinary contribution of Australia’s most distinguished melanoma clinicians and researchers is being celebrated today.
Congratulations to Professor Richard Scolyer who was awarded the William O. Russell/Joanne Vandenberge Hill Award of Excellence in Pathology.
A Day in the Life Of... Serigne Lo, Research and BioStatistics Manager at Melanoma Institute Australia
Jay was your typical Aussie bloke – a truck driver, husband, dad and mate to many. Then he got melanoma. His cancer diagnosis turned his life upside down.
Clair faced an impossible choice – risk delivering her baby early, or delay potentially life-saving melanoma treatment
Little Madi misses her Dad. But she is determined to honour his memory and support life-saving melanoma research.
Toyota and country music fans invited to tip their hat to help tackle Australia's national cancer – melanoma
Melanoma Institute Australia has teamed up with the Toyota Country Music Festival 2018 in Tamworth!
MIA's dermatologist shares her knowledge with GPs on debunking myths and controversies on sunscreen.
Shannan Ponton thought he was invincible – he wasn’t. But his melanoma battle ended up saving more than his own life.
Researchers have demonstrated that immunotherapy is highly effective in treating a rare form of melanoma – a result that is surprising due to the nature of the tumour.
Innovation is helping to prevent melanoma developing in the first place.
Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.
A prestigious Fellowship has been awarded to fund research that will change the way melanoma treatment is assessed in the future.
New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.